Loading [MathJax]/jax/output/SVG/jax.js
Overview Topical Sections

SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses

  • Received: 26 July 2022 Revised: 24 October 2022 Accepted: 06 November 2022 Published: 16 November 2022
  • In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the globe, even in countries where vaccination programs have been strongly implemented. In these regions in 2021, a reduction in the number of hospitalizations and deaths compared to 2020 was observed. This decrease is certainly associated with the introduction of vaccination measures. The process of the development of effective vaccines represents an important challenge. Overall, the breakthrough infections occurring in vaccinated subjects are in most cases less severe than those observed in unvaccinated individuals. This review examines the factors affecting the immunogenicity of vaccines against SARS-CoV-2 and the possible role of nutrients in modulating the response of distinct immune cells to the vaccination.

    Citation: Sirio Fiorino, Andrea Carusi, Wandong Hong, Paolo Cernuschi, Claudio Giuseppe Gallo, Emanuele Ferrara, Thais Maloberti, Michela Visani, Federico Lari, Dario de Biase, Maddalena Zippi. SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses[J]. AIMS Microbiology, 2022, 8(4): 422-453. doi: 10.3934/microbiol.2022029

    Related Papers:

    [1] Xiangyang Ren, Shuai Chen, Kunyuan Wang, Juan Tan . Design and application of improved sparrow search algorithm based on sine cosine and firefly perturbation. Mathematical Biosciences and Engineering, 2022, 19(11): 11422-11452. doi: 10.3934/mbe.2022533
    [2] Anlu Yuan, Tieyi Zhang, Lingcong Xiong, Zhipeng Zhang . Torque control strategy of electric racing car based on acceleration intention recognition. Mathematical Biosciences and Engineering, 2024, 21(2): 2879-2900. doi: 10.3934/mbe.2024128
    [3] Shijing Ma, Yunhe Wang, Shouwei Zhang . Modified chemical reaction optimization and its application in engineering problems. Mathematical Biosciences and Engineering, 2021, 18(6): 7143-7160. doi: 10.3934/mbe.2021354
    [4] Guowen Li, Ying Xu, Chengbin Chang, Sainan Wang, Qian Zhang, Dong An . Improved bat algorithm for roundness error evaluation problem. Mathematical Biosciences and Engineering, 2022, 19(9): 9388-9411. doi: 10.3934/mbe.2022437
    [5] Shenghan Li, Linlin Ye . Multi-level thresholding image segmentation for rubber tree secant using improved Otsu's method and snake optimizer. Mathematical Biosciences and Engineering, 2023, 20(6): 9645-9669. doi: 10.3934/mbe.2023423
    [6] Chikun Gong, Yuhang Yang, Lipeng Yuan, Jiaxin Wang . An improved ant colony algorithm for integrating global path planning and local obstacle avoidance for mobile robot in dynamic environment. Mathematical Biosciences and Engineering, 2022, 19(12): 12405-12426. doi: 10.3934/mbe.2022579
    [7] Yijie Zhang, Yuhang Cai . Adaptive dynamic self-learning grey wolf optimization algorithm for solving global optimization problems and engineering problems. Mathematical Biosciences and Engineering, 2024, 21(3): 3910-3943. doi: 10.3934/mbe.2024174
    [8] Ning Zhou, Chen Zhang, Songlin Zhang . A multi-strategy firefly algorithm based on rough data reasoning for power economic dispatch. Mathematical Biosciences and Engineering, 2022, 19(9): 8866-8891. doi: 10.3934/mbe.2022411
    [9] Junjie Liu, Hui Wang, Xue Li, Kai Chen, Chaoyu Li . Robotic arm trajectory optimization based on multiverse algorithm. Mathematical Biosciences and Engineering, 2023, 20(2): 2776-2792. doi: 10.3934/mbe.2023130
    [10] Di-Wen Kang, Li-Ping Mo, Fang-Ling Wang, Yun Ou . Adaptive harmony search algorithm utilizing differential evolution and opposition-based learning. Mathematical Biosciences and Engineering, 2021, 18(4): 4226-4246. doi: 10.3934/mbe.2021212
  • In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the globe, even in countries where vaccination programs have been strongly implemented. In these regions in 2021, a reduction in the number of hospitalizations and deaths compared to 2020 was observed. This decrease is certainly associated with the introduction of vaccination measures. The process of the development of effective vaccines represents an important challenge. Overall, the breakthrough infections occurring in vaccinated subjects are in most cases less severe than those observed in unvaccinated individuals. This review examines the factors affecting the immunogenicity of vaccines against SARS-CoV-2 and the possible role of nutrients in modulating the response of distinct immune cells to the vaccination.



    The sparrow search algorithm [1] is a new SI algorithm put forward by Xue in 2020. By observing the predation behavior and reconnaissance mechanism of sparrow populations in nature, the intelligent algorithm has the advantages of high search accuracy, fast optimization and few parameters, which has attracted more and more scholars' attention. Furthermore, as a kind of SI algorithm, the sparrow search algorithm also has some shortcomings, such as premature convergence and easy to fall into local optimization.

    For the improvement and application of the sparrow search algorithm, many scholars have done a lot of research. GAO et al. [2] put forward a multi-strategy improved evolutionary sparrow search algorithm by adding tent chaos in the initialization population phase, which sped up convergence and improved convergence precision. Additionally, the algorithm used a greedy strategy to fully utilize each individual sparrow to increase its capability to deal with the global optimal solution. Liu et al. [3] added the circle chaotic mapping into the sparrow search algorithm to improve the global search ability of the algorithm in population initialization and introduce t-distribution in the position update formula for different iteration cycles of the sparrow to facilitate the algorithm to jump out of the local optimum. Ren et al. [4] proposed a sparrow search algorithm based on sine cosine and firefly disturbance. The sine cosine algorithm with random inertia weight was added to the finder position update, and all sparrows were updated using the optimal sparrows obtained by firefly disturbance method to improve the sparrows search ability. Brezočnik et al. [5] analyzed various methods of SI algorithms in feature selection problems, provided a unified framework for SI algorithms to solve feature selection and discussed the application prospects of feature selection methods based on SI in different application fields. Zhang et al. [6] proposed a random configuration network based on the chaotic sparrow search algorithm, the chaotic sparrow search algorithm mainly uses logistic mapping, adaptive hyperparameters and variational operators to enhance the global optimization capability of the sparrow search algorithm. The accuracy of the random configuration network is affected by the allocation and selection of some network parameters. The chaotic sparrow search algorithm is used to optimize the random configuration network to provide better parameters for the network. Fan et al. [7] used the hybrid sparrow search algorithm to optimize the hyperparameters of the deep learning algorithm. The hybrid sparrow search algorithm is a hyperparameter optimization method combining the sparrow search algorithm and particle swarm optimization, which avoids the local optimal solution in the sparrow search algorithm and the search efficiency of the particle swarm optimization algorithm. Dong et al. [8] used an improved multi-objective sparrow search algorithm to distribute the capacity of distributed power generation, introduced Levy flight strategy to enhance the ability of multi-objective sparrow search algorithm to jump out of local optimum and established a multi-objective optimization model with investment cost, environmental protection and power supply quality and used the multi-objective sparrow search algorithm to optimize the solution. Zhu et al. [9] used an improved sparrow search algorithm to optimize the control of a chilled water system, disturbed the sparrow by random walk strategy to improve the global search ability of the sparrow and added Gaussian mutation in the iterative process of the algorithm to enhance the local search capability, which effectively solves the problem of large time lag and inertia of the chilled water system. Li et al. [10] proposed an improved sparrow search algorithm to solve the problem of super-parameter selection of the support vector machine (SVM) model. Through a new dynamic adaptive t- distribution mutation, the performance of the sparrow search algorithm was enhanced, and the proposed method can effectively improve the prediction accuracy.

    Although the aforementioned revised approaches have helped the algorithm's search performance to some degree, there is still much potential for advancement. In order to improve the algorithm's convergence performance and convergence accuracy simultaneously, we propose a multi-strategy improved sparrow search algorithm based on the existing research. The major contributions of this article are as follows:

    1) A multi-strategy improved sparrow search algorithm (ISSA) has been proposed, with mostly the following three points.

    a) Dynamically adjust the number of discoverers and joiners in the population, which facilitates the algorithm to make a balance between search and global search.

    b) The update the strategy of the mining phase of the honeypot optimization algorithm (HBA) is introduced to improve the location update of the joiners in SSA and enhance the global exploitation capability of the algorithm.

    c) The optimal position of the discoverer is disturbed by the disturbance operator and levy flight to increase the algorithm's capacity to depart from the local optimum.

    2) Compared with five basic algorithms on 13 benchmark functions, the effectiveness of the proposed algorithm is verified. The results demonstrate that the proposed algorithm has faster convergence speed and higher convergence accuracy in solving functional optimization problems.

    3) Applying ISSA to the pilot optimization problem in channel estimation, the bit error rate is greatly improved, indicating the superiority of the proposed algorithm in engineering applications.

    The organizational structure of the remaining parts of this article is as follows: The second section discusses the basic sparrow search algorithm, describing the population distribution and update method of the original algorithm. In the third section, an improved sparrow search algorithm (ISSA) was proposed, and three improved strategies were introduced. In the fourth section, we conducted simulation experiments on the proposed method, conducted experiments on unimodal and multimodal test functions and conducted Wilcoxon rank sum tests. The fifth section applies the proposed algorithm to channel estimation in the OFDM system, and finally, a summary is provided in the sixth section.

    The sparrow search algorithm is put forward by observing the predation behavior and reconnaissance mechanism of sparrow populations in nature. The sparrow population is divided into two categories: finders and participants, in which the finders account for 30% of the population and supply the foraging guidance for the whole sparrow population, and the remaining sparrows are participants, which search for food around the discoverers with the best fitness value. Additionally, certain sparrows were chosen at random to serve as scouts to add an early warning mechanism.

    In SSA, discoverers are sparrows with higher fitness values and they supply foraging directions and locations for the joiners. The location formula of the discoverers is as follows:

    Xt+1i={Xtiexp(iaT) R2<STXti+QLR2ST (2.1)

    t indicates the current iteration number, T is the maximum iteration number, Xti indicates the location of the i sparrow in the t iteration, a is the random number of (0, 1), Q satisfies normal distribution, L is the matrix of 1×D with all elements in it are 1 and D is the maximum dimensional value. R2 and ST represent the alert values and security values. When R2<ST, it means that the current environment is free of pouncers and the discoverer can conduct an extensive search. When R2ST, it indicates that a portion of the population has found a predator and an alert has been issued, and all sparrows need to move closer to the safety zone at this time.

    Joiners always observe the behavior of discoverers and they adjust their positions based on the information from the discoverers. The location formula of the participants is as follows:

    Xt+1i={Qexp(XworstXtii2)i>n/2Xtp+|XtiXtp|A+Lotherwise (2.2)

    where Xworst denotes the global worst location, Xtp denotes the optimal position currently occupied by the discoverer, A is a matrix of 1×D with values randomly assigned to 1 or -1 and A+=AT(AAT)1. When i>n/2, it indicates that the i sparrow with low adaptability is not getting sufficient nutrition and needs to fly to other places to forage for better food, otherwise, the joiner searches near the optimal location searched by the finder.

    During sparrow foraging, in order to avoid attacks from predators, the population randomly selects sparrows from 10-20% to scout, and when danger is detected, individuals in the population will make corresponding adjustments. The location formula of the scouts is as follows:

    Xt+1i={Xti+β|XtiXtbest| fi>fgXti+K(|XtiXtworst|(fifw)+ε) fi=fg (2.3)

    Xtbest is the current global optimum position and β is the step control variable, which satisfies the standard normal distribution, K is a random number between (-1, 1) and fgandfw are the global highest and lowest fitness values, respectively. ϵ is a constant to prevent the denominator from being 0. When fi>fg, the sparrow is at the edge of the population and is vulnerable to attack by predators, sparrows need to move to the best individual position of the population. fi=fg indicates that the sparrow in the middle of the population is aware of the danger and needs to move closer to other sparrows to reduce the risk of being pounced.

    First, the population dynamic adjustment strategy is used to control the number of sparrow population discoverers and joiners. The number of discoverers and joiners of the original sparrow search algorithm is fixed and the discoverers perform global search and the joiners perform local search. With the increase of iterations, the algorithm tends to fall into a local optimum and requires more discoverers for global search, so the population dynamic adjustment strategy is designed to balance the algorithm's global search and local search capabilities of the algorithm to avoid falling into a local optimum. Then, the joiner's position update formula in the algorithm is improved. The joiner's position update formula for conducting global search in the original algorithm is a step length multiplied by a normally distributed random number, which is determined by the current position and the global worst position, and only the global worst position is considered, while the global optimal position is ignored. In the improved position update formula, the mining phase of the honeypot optimization algorithm (HBA) is introduced, and the global optimal position and the global worst position are added to enhance the global exploration capability of the algorithm. Finally, the optimal position of the population discoverer is perturbed using the perturbation operator and levy flight strategy. In the original algorithm, the joiner always searches near the optimal position of the discoverer, the optimal position of the discoverer may be in the local optimum, at which time it is necessary to perturb the move step using the perturbation operator. Levy flight is added at the optimal position to enhance the ability of the algorithm to depart the local optimum.

    Discoverers in the sparrow population primarily undertake worldwide searches, while joiners' activity is classified into two categories. One portion of the joiners conducts local searches in the discoverer's optimal location, while the other part conducts worldwide searches. The number of discoverers and joiners in the sparrow population is fixed in the original sparrow search algorithm, and a fixed number of discoverers always undertake global searches in each iteration. The joiners then seek, depending on the direction supplied by the discoverer. Once the discoverer's ideal location falls into a local optimum, a set number of joiners do a local search at the optimal point, followed by a global search, making it difficult to exit the local optimum. Later in the algorithm iteration process, a bigger number of discoverers are necessary to conduct global searches in order to explore better sites all over the world. Moreover, a greater proportion of sparrows are required to do global searches among joiners. To balance the algorithm's ability to do global and local searches, a dynamic adjustment approach for the number of sparrow discoverers and participants has been created. The dynamic adjustment strategy is as follows:

    PD1=PD+R1(t/T)PD2=R2+R3(t/T) (3.1)

    PD1 is the proportion of improved discoverers, PD is the original discoverers' ratio, generally set at 20%, R1 is the upper limit for the set discoverer ratio column increase, which is equal to 0.1, t is the current iteration number and T is the maximum iteration number. PD2 is the comparison column of sparrows in the population for global search, R2 is the original set ratio, generally set to 0.5, R3 is the upper limit of the increased global search sparrow ratio, taken as 0.1. With the increase of the number of times, the number of discoverers and global search joiners are increasing, and the number of joiners searching near the optimal position of the discoverer is decreasing, which is conducive to the algorithm to jump out of the local optimum and increase the ability of global search.

    The honeypot optimization algorithm [11] is a new meta-heuristic intelligent algorithm proposed by Fatma A. Hashim in 2021. The HBA algorithm is mainly used to find the optimal by mimicking the honey badger foraging behavior, the algorithm model has few parameters and has a better global search capability. There are two phases in the search process, tracking around the excavation and following existing guides to find foraging honey. Thus, we mainly introduce the update strategy of the tracking around the excavation phase of HBA, and in the excavation phase, the formula for updating the position of the honeypot algorithm is as follows:

    xnew=xprey+F×β×I×xprey+F×r1×α×di×|cos(2πr2)×[1cos(2πr3)]| (3.2)

    xprey is the location of the prey and is the best location globally. β1 (Default is 6) represents the honey badger's ability to find food. di is the distance between the prey and the i th honey badger, and r1, r2 and r3 are three different random numbers between 0 and 1. F as a sign to change the search direction, the following equation is used to update:

    F={1 r40.51 else (3.3)

    I is the definition of olfactory intensity, if the odor is high, the movement will be fast and vice versa, which is given by the inverse square law. α is the time-varying search decay factor, which indicates the randomness of the search process over time. α value decreases with increasing number of iterations and is defined by equation.

    I=r5×S4πd2S=(xixi+1)2d=xpreyxiα=2×exp(ttmax) (3.4)

    In the mining phase of the honeypot optimization algorithm, the search is mainly carried out near the global optimal position, and two random steps are added. In other words, a position is randomly selected from the current and optimal positions as the update position for the next iteration. In the original sparrow search algorithm, the update formula of the participant's location for global search only takes into account the current and worst positions, leaving out the ideal position. The search strategy of the honeypot algorithm is applied to the position update formula of the joiners in SSA, and the optimal position of the discoverer is introduced into the global search update formulas, randomly select a position between the optimal and worst positions as the step size for position update in the next iteration. The improved discoverer location update formula is as follows:

    Xt+1i={Qexp(Xtp+F×β×I×(XtpXworst)i2) i>n.(1PD2)Xtp+|XtiXtp|A+L otherwise (3.5)

    Among them, n represents the number of sparrow populations. When i>n(1PD2), it indicates that the current enrollee has not found a better location, so it is necessary to expand the search interval for global search. In other cases, the participants need to use the information provided by the discoverer for local search.

    In the original algorithm, the joiner is searching at the optimal position found by the discoverer, and in the multi-peak test function, if the discoverer finds the local optimal location, then the joiner searches at the local optimal position of the algorithm. If it is difficult to depart from the local optimum, it is necessary to perturb the joiner position update formula with a small perturbation when the current sparrow's fitness value is low, and a larger perturbation when the fitness value is larger, which is also affected by the number of iterations, while adding levy flight [12] near the optimal position of the discoverer XtP to facilitate the algorithm to depart from the local optimum. The perturbation operator and levy flight are defined as follows:

    w=wmin+(wmaxwmin)×(fifgfwfg)×tTLevy(β)=αu|v|1β (3.6)

    where w is the current perturbation, wmax and wmin are the highest and lowest perturbations, respectively, which take the values of 0.5 and 1.5 here, Levy(β) is the levy flight's step size, u, v satisfy the normal distribution and α is the step scaling factor. In the experiment, levy flight requires small changes, so the value of a should not be too large. After repeated experiments, we found that the performance is best when α is set to 0.01 and β is the random number of [0, 2], when taken as 1.5. Levy flight involves performing small step size transformations over a long period of time, with occasional large step size transformations. By introducing levy flight into the optimal position in the local search formula of the joiners, the optimal position can be perturbed, resulting in a small deviation of the discoverer's optimal position with a high probability and a large deviation with a low probability. The joiners not only retain the discoverer's position information, but helps the algorithm depart from local optima. The improved algorithm updates the formula as follows:

    Xt+1i={Qexp(Xtp+F×β×I×(XtpXworse)i2) i>n.(1PD2)Levy(β)Xtp+w|XtiLevy(β)Xtp|A+L otherwise (3.7)

    n represents the number of sparrow populations. In the global search stage of the discoverer, we added the search strategy of the honeypot algorithm, expanding the search space and global search ability of the algorithm. In the local search stage, we added perturbation operators and levy flight, which can break free from the constraints of the optimal position of the discoverer and have the ability to jump out of the local optimum.

    The specific implementation steps of the ISSA algorithm are as follows:

    Step 1. Set the population size N, maximum number of iterations T, scout ratio SD, alarm value R2 and security value ST.

    Step 2. Calculate each sparrow's fitness value individually using the fitness function, then rank them, record the best position Xbest and the best fitness value fg, the worst position Xworst and the worst fitness value fw in the population.

    Step 3. Calculate the proportion of discoverers PD1 and the proportion of joiners performing a global search PD2 according to Eq (3.1).

    Step 4. The population is separated into discoverers and participants according to the ratio calculated in step 3, and the locations of discoverers and joiners are updated according to Eqs (2.1) and (3.7).

    Step 5. Update the location of the scout according to Eq (2.3).

    Step 6. Update the best position Xbest and best fitness value fg, the worst position Xworst and the worst fitness value fw.

    Step 7. When the maximum number of iterations has been achieved, the best outcome is produced and the algorithm is finished, otherwise go to step 3.

    The pseudocode of the ISSA algorithm is shown in Table 1.

    Table 1.  Pseudocode for ISSA.
    Algorithm multi-strategy improved sparrow search optimization algorithm
    Input: the population size N, maximum number of iterations T, scout ratio SD, alarm value R2 and security value ST.
    Output: global minimum fitness value fbest and the global optimal position Xbest
    1. set t = 0
    2. initialize the position vector of sparrow individuals Xti(i=1,2,...,N)
    3. calculate the fitness value of each sparrow individual based on the fitness function and sort them, recording the best position Xbest and best fitness value fg, the worst position Xworst and the worst fitness value fw
    4. while (t < T) do
        calculate the proportion of discoverers PD1 and the proportion of global searchers PD2 according to Eq (3.1)
        For i=1:NPD1 do
        update the discoverer's position Xti according to Eq (2.1) and calculate the fitness value fi
        update discoverer's optimal location Xtp
        End for
        For i=NPD1+1:N do
        update the position Xti of the enrollee according to Eq (3.7) and calculate the fitness value fi
        End for
        For i=1:N0.2 do
        update the position Xti of the scout according to Eq (2.3) and calculate the fitness value fi
        End for
        update the best position Xbest and best fitness value fg, the worst position Xworst and the worst fitness value fw
        t = t + 1
      End while
    5. return fbest, Xbest

     | Show Table
    DownLoad: CSV

    In order to test the performance of the improved sparrow algorithm (ISSA), 13 distinct standard test functions were selected for testing. To ensure the reliability of the algorithm, these functions include single-peak and multi-peak. F1F7 is the single-peak benchmark test function and F8F13 is the multi-peak benchmark test function, and the specific function information is shown in Table 2, where D represents the dimension of function, range represents the upper and lower limits of each dimension and Fmin is the theoretical optimal value of the test function.

    Table 2.  Benchmarking function.
    Function D Range Fmin
    F1(x)=ni=1x2i 30 [100,100]  0
    F2(x)=ni=1|xi|+ni=1|xi| 30 [100,100]  0
    F3(x)=ni=1(nj=1xj)2 30 [100,100]  0
    F4(x)=max{|xi|,1in}  30 [100,100]  0
    F5(x)=ni=1[100(xi+1xi)2+(xi1)2] 30 [100,100]  0
    F6(x)=ni=1(|xi+0.5|2)  30 [100,100]  0
    F7(x)=ni=1ix4i+random[0,1) 30 [100,100]  0
    F8=ni=1xisin(|xi|)  30 [500.500] 12569.5
    F9=ni=1[x2i10cos(2πxi) + 10] 30 [5.12, 5.12] 0
    F10 = - 20exp( - 0.21/nni=1x2i) - exp(1/nni=1cos(2πxi)) + 20 + e   30 [32,32] 0
    F11=1/4000ni=1x2ini=1cos(xi/i) + 1 30 [600,600]  0
    F12=π/n{10sin(πyi)+y}+ni=1u(xi,10,100,4){y=n1i=1(yi1)2[1+10sin2(πyi+1)]+(yn1)2 yi=1+(xi+1)/4u(xi,a,k,m)={k(xia)m xi>a0 a<xi<ak(xia)m xi<a  30 [50,50]   0
    F13=0.1{sin2(3πxi)+y}+ni=1u(xi5,100,4) 0 {y=ni=1(xi1)2[1+10sin2(3πxi+1)]+(xn1)2[1+sin2(2πxn]yi=1+(xi+1)/4 u(xi,a,k,m)={k(xia)m xi>a a<xi<ak(xia)m xi<a  30   [-50, 50]  0

     | Show Table
    DownLoad: CSV

    The improved algorithms in this paper were compared with the initial sparrow search algorithm (SSA) [1], gray wolf algorithm (GWO) [13], particle swarm algorithm (PSO) [14], whale algorithm (WOA) [15] and harris hawk algorithm (HHO) [16] with a population setting of 50 and an iteration number of 500, which were run in 13 basic test functions. To verify the improved accuracy and reliability of the algorithms, each algorithm was run 30 times independently to obtain the best value, the worst value, the mean value and the standard deviation. The experimental data are shown in Table 3.

    Table 3.  Statistical results of test functions.
    Function Algorithm Best Value Worst Value Mean Standard Deviation
    F1 ISSA 0 0 0 0
    SSA 0 3.1864e-167 1.0621e-168 0
    GWO 1.3421e-35 9.5061e-33 1.8382e-33 2.2221e-33
    PSO 6.2326e-01 4.0682e+00 1.9043e+00 7.8942e-01
    WOA 1.2048e-97 2.4256e-79 8.0858e-81 4.4285e-80
    HHO 3.1580e-115 1.1840e-101 4.3698e-103 2.1566e-102
    F2 ISSA 0 0 0 0
    SSA 0 8.0286e-73 2.7546e-74 1.4649e-73
    GWO 1.0171e-20 1.6197e-19 1.8382e-33 4.0183e-20
    PSO 2.1010e+00 8.8391e+00 3.7033e+00 1.5229e+00
    WOA 1.1144e-60 1.6915e-51 5.7178e-53 3.0868e-52
    HHO 1.5936e-63 5.4539e-52 3.7851e-53 1.2047e-52
    F3 ISSA 0 0 0 0
    SSA 0 3.2933e-97 1.0977e-98 6.0128e-98
    GWO 8.8323e-05 1.1289e-01 1.4057e-02 2.4901e-02
    PSO 8.3009e+02 2.3863e+03 1.5807e+03 3.6382e+02
    WOA 8.7232e+04 2.2099e+05 1.5590e+05 3.0711e+04
    HHO 6.6572e-104 7.5648e-80 2.6622e-81 1.3800e-80
    F4 ISSA 0 0 0 0
    SSA 0 3.3360e-79 1.1304e-80 6.0882e-80
    GWO 1.8481e-09 2.0828e-07 2.1830e-08 3.6978e-08
    PSO 1.5610e+00 2.1636e+00 1.8451e+00 1.5855e-01
    WOA 1.0979e+00 8.0088e+01 4.0919e+01 2.6874e+01
    HHO 6.5401e-59 9.4584e-51 6.7262e-52 1.7779e-51
    F5 ISSA 5.0702e-08 6.6256e-04 1.2085e-04 1.8009e-04
    SSA 8.0695e-09 6.9311e-04 4.3963e-05 4.6962e-05
    GWO 2.5409e+01 2.7947e+01 2.6763e+01 6.3084e-01
    PSO 2.0406e+02 2.0100e+03 6.2682e+02 3.6003e+02
    WOA 2.6745e+01 2.8735e+01 2.7510e+01 5.1895e-01
    HHO 1.4009e-05 4.0703e-02 6.4049e-03 9.0201e-03
    F6 ISSA 3.2625e-09 1.7089e-04 8.5505e-06 3.0861e-05
    SSA 8.3945e-14 7.5595e-08 3.5915e-09 8.5505e-06
    GWO 2.9951e-05 1.0066e+00 4.0874e-01 2.9877e-01
    PSO 4.7765e-01 3.4218e+00 1.6663e+00 8.5085e-01
    WOA 1.4147e-02 4.1637e-01 7.8582e-02 8.2848e-02
    HHO 5.8989e-08 4.2385e-04 5.3248e-05 9.4043e-05
    F7 ISSA 5.008e-06 2.7466e-04 7.4644e-05 7.6159e-05
    SSA 2.3711e-05 1.2953e-03 3.1855e-04 3.4020e-04
    GWO 1.9770e-04 3.3204e-03 1.1363e-03 8.0935e-04
    PSO 2.7306e+00 3.7821e+01 1.1836e+01 9.0431e+00
    WOA 3.4660e-05 7.3887e-03 2.0482e-03 2.1898e-03
    HHO 2.7638e-06 4.1441e-04 9.7169e-05 1.0390e-04
    F8 ISSA -1.2569e+04 -7.4191e+03 -1.1887e+04 1.2782e+03
    SSA -9.2134e+03 -6.5663e+03 -8.2420e+03 5.5573e+02
    GWO -7.9246e+03 -5.0894e+03 -6.4129e+03 6.0860e+02
    PSO -8.8566e+03 -3.1261e+03 -6.5984e+03 1.2449e+03
    WOA -1.2569e+04 -8.7211e+03 -1.1390e+04 1.0232e+03
    HHO -1.2569e+04 -1.2346e+04 -1.2562e+04 4.0822e+01
    F9 ISSA 0 0 0 0
    SSA 0 0 0 0
    GWO 0.0000e+00 1.1286e+01 2.6422e+00 3.4938e+00
    PSO 8.9641e+01 2.2799e+02 1.5502e+02 3.2893e+01
    WOA 0.0000e+00 1.2864e+02 4.2878e+00 2.3485e+01
    HHO 0 0 0 0
    F10 ISSA 8.8818e-16 8.8818e-16 8.8818e-16 0
    SSA 8.8818e-16 8.8818e-16 8.8818e-16 0
    GWO 3.6415e-14 5.7732e-14 4.4231e-14 5.2281e-15
    PSO 1.5364e+00 3.2912e+00 2.3790e+00 4.6682e-01
    WOA 8.8818e-16 7.9936e-15 4.5593e-15 2.1847e-15
    HHO 8.8818e-16 8.8818e-16 8.8818e-16 0.0000e+00
    F11 ISSA 0 0 0 0
    SSA 0 0 0 0
    GWO 0.0000e+00, 2.1431e-02 3.5261e-03 6.2577e-03
    PSO 4.1021e-02 1.7217e-01 8.9648e-02 3.1821e-02
    WOA 0.0000e+00 1.0747e-01 3.5825e-03 1.9622e-02
    HHO 0 0 0 0
    F12 ISSA 2.5567e-14 1.0504e-05 8.2340e-07 2.0803e-06
    SSA 7.2294e-12 1.1659e-07 1.3818e-08 2.4578e-08
    GWO 7.0921e-06 6.2996e-02 2.6369e-02 1.2897e-02
    PSO 3.8811e-03 2.2942e-01 3.3481e-02 4.6857e-02
    WOA 1.5657e-03 9.3638e-02 9.9804e-03 1.6518e-02
    HHO 1.0840e-07 1.7123e-05 3.7877e-06 4.1722e-06
    F13 ISSA 5.0710e-10 2.5597e-05 2.9599e-06 5.4241e-06
    SSA 8.9927e-10 2.0121e-06 1.9305e-07 3.8369e-07
    GWO 4.7668e-05 7.5600e-01 4.0804e-01 2.1821e-01
    PSO 2.1080e-01 7.0900e-01 4.0368e-01 1.4349e-01
    WOA 2.7551e-02 5.8833e-01 2.1351e-01 1.5308e-01
    HHO 1.2643e-09 2.2246e-04 3.6326e-05 5.1000e-05

     | Show Table
    DownLoad: CSV

    As shown in Table 3, for the single-peak test function F1F4, the proposed ISSA has a higher finding effect than SSA, GWO, PSO, WOA and HHO. All can find the theoretical optimal value with a standard deviation of 0, and the optimization effect is stable. For the F5 and F6 functions, ISSA's optimization is lower than that of SSA, but the accuracy loss is not great. For the F7 function, ISSA has little improvement, and the standard deviation and mean value are the lowest. For the F8 function, HHO achieves the best result, the optimal value and the average value are close to the theoretical optimal value, the performance of ISSA has improved significantly and the average value has been greatly enhanced compared with SSA. For the F9F11 function, ISSA, SSA and HHO have similar performance and have discovered the test function's ideal value, which means that ISSA has maintained the optimization-seeking ability of SSA and has not reduced the optimization-seeking ability of the algorithm. For the F12F13 function, SSA outperforms ISSA, which comes in second only to SSA and also achieves good optimization results. In summary, ISSA performs poorly on F5, F6, F12, F13 and achieves better performance on other test functions.

    In order to highlight the superiority of the algorithm more intuitively and to facilitate the presentation of experimental results, the first 12 test functions were selected for testing, each algorithm was independently executed 30 times and the average convergence curves of the test functions were plotted according to the fitness function value and the number of iterations. Specifically, as shown in Figure 1, it can be observed that the improved algorithm in this paper has a faster convergence speed and higher convergence accuracy on most test functions. In the F1F4 function, the improved algorithm is able to converge to 0, and ISSA has a huge improvement in both convergence speed and convergence accuracy. In F5, F6, ISSA has poorer performance compared to SSA, but there is no major loss in accuracy, and it is still more accurate than GWO, HHO, PSO and WOA. In the F7 function, ISSA has the greatest optimization finding precision among the six algorithms, and in the F8 function, ISSA has lower performance than HHO, but still higher than SSA, GWO, PSO and WOA. In F9F11, ISSA, SSA and HHO all find the theoretical optimum, but ISSA has higher convergence speed, and the convergence speed improvement is very large. In the F12 function, the convergence accuracy of ISSA is lower than that of SSA, but the difference is not large. In summary, ISSA has good performance in both single-peak and multi-peak functions.

    Figure 1.  Average convergence curve of test function.

    Due to the improvement of the original algorithm, ISSA has higher computational complexity, and the running time can indirectly reflect the complexity of the algorithm. Therefore, we have made statistics on the running time of each algorithm, in which the number of iterations is set to 500, and the population is set to 50, running for a total of 100 times. The average running time of the six algorithms obtained is in Table 4, and the time unit is seconds. It can be seen that the average running time of ISSA is longer than that of SSA and other algorithms. The running time of SSA is longer than that of GWO and PSO, because these two algorithms are traditional SI algorithms with low complexity and poor performance in optimization, so the time is short. HHO and WOA are new SI algorithms, and the calculation time of SSA is longer than WOA and shorter than HHO. ISSA is improved on the basis of SSA, adding three strategies, which increases the computational complexity and running time, but has better convergence speed and accuracy.

    Table 4.  Function run schedule.
    Function ISSA SSA GWO PSO WOA HHO
    F1 4.5601e-01 2.5262e-01 1.8739e-01 2.2744e-01 8.7704e-02 1.1250e-01
    F2 5.2522e-01 2.9624e-01 2.1472e-01 3.1399e-01 1.0855e-01 1.3769e-01
    F3 1.7906e+00 1.5361e+00 1.2834e+00 2.6802e+00 1.1424e+00 1.1655e+00
    F4 4.7572e-01 2.6550e-01 1.8347e-01 2.7232e-01 8.5454e-02 1.1064e-01
    F5 6.4553e-01 2.9481e-01 2.2528e-01 4.0675e-01 1.1273e-01 1.4183e-01
    F6 5.7290e-01 2.4893e-01 1.8573e-01 3.1503e-01 8.5637e-02 1.1233e-01
    F7 7.2310e-01 3.9009e-01 2.9794e-01 5.2787e-01 1.9761e-01 2.2544e-01
    F8 6.4317e-01 3.0312e-01 2.2628e-01 4.2769e-01 1.3433e-01 1.5224e-01
    F9 4.5420e-01 2.6201e-01 1.9559e-01 3.4739e-01 1.0720e-01 1.1922e-01
    F10 5.1214e-01 2.9018e-01 2.1408e-01 3.9707e-01 1.2929e-01 1.4188e-01
    F11 5.5401e-01 3.2185e-01 2.3612e-01 6.4961e-01 1.4446e-01 1.6124e-01
    F12 9.1667e-01 7.0514e-01 5.4576e-01 1.1828e+00 4.4232e-01 4.6976e-01
    F13 1.0942e+00 7.1022e-01 5.4974e-01 1.1907e+00 4.4634e-01 4.7318e-01

     | Show Table
    DownLoad: CSV

    To more thoroughly evaluate the effectiveness of the proposed algorithm, we introduce the Wilcoxon rank sum test [17] to test the significance of the optimal results of ISSA algorithm and other algorithms under 30 independent runs to evaluate whether there is a significant difference between the proposed ISSA and other algorithms. The original hypothesis is H0 : there is no significant difference between the two algorithms, and the alternative hypothesis is H1 : there is a significant difference between the two algorithms. When P<5%, the original hypothesis H0 is rejected and the alternative hypothesis H1 is accepted, which means that there is a significant difference between the two algorithms, and when P>5%, the original hypothesis is accepted, which implies that there is no significant difference between the two algorithms, indicating that the two algorithms are equivalent in finding the optimal results. The rank sum test results of ISSA and SSA, GWO, PSO, WOA and HHO are shown in Table 5, where N/A indicates that the two algorithms have equivalent performance and cannot be compared.

    Table 5.  Wilcoxon rank sum test P value table.
    Function SSA GWO PSO WOA HHO
    F1 5.8522e-09 1.2118e-12 1.2118e-12 1.2118e-12 1.2118e-12
    F2 5.7720e-11 1.2118e-12 1.2118e-12 1.2118e-12 1.2118e-12
    F3 1.9346e-10 1.2118e-12 1.2118e-12 1.2118e-12 1.2118e-12
    F4 1.6572e-11 1.2118e-12 1.2118e-12 1.2118e-12 1.2118e-12
    F5 1.4532e-01 3.0199e-11 3.0199e-11 3.0199e-11 1.4733e-07
    F6 8.1014e-10 3.0199e-11 3.0199e-11 3.0199e-11 1.3111e-08
    F7 6.0459e-07 3.0199e-11 3.0199e-11 1.4643e-10 8.0727e-03
    F8 1.6132e-10 3.0199e-11 3.4971e-09 8.5641e-04 3.2651e-02
    F9 N/A 1.1586e-11 1.2118e-12 1.2118e-12 N/A
    F10 N/A 9.0844e-13 1.2118e-12 1.0793e-09 N/A
    F11 N/A 2.7880e-03 1.2118e-12 1.2118e-12 N/A
    F12 4.9752e-11 3.0199e-11 3.0199e-11 3.0199e-11 2.1959e-07
    F13 3.4971e-09 3.0199e-11 3.0199e-11 3.0199e-11 1.4733e-07

     | Show Table
    DownLoad: CSV

    According to Table 3, the performance of ISSA is equivalent to that of SSA and HHO in the F9F11 function, which shows that the three algorithms can determine the best value of the test function pair in each experiment. According to the convergence curve, it is known that ISSA has faster convergence velocity and higher stability. The rest of the p-values are less than 0.05, indicating that there is a significant difference between the proposed ISSA and the other algorithms.

    Figure 2 shows the boxplot of the optimal value for each test function of six algorithms. Each algorithm runs independently 50 times in the test function, selecting F1, F3, F5 and F7 from the single-peak function and F8 and F11 from the multi-peak function. It can be seen that in F1 and F3, the ISSA algorithm has a maximum, minimum and median of 0 in the boxplot, which is much smaller than other algorithms, indicating that ISSA has strong balance ability and high robustness. In F5, the optimal value accuracy of ISSA is lower than ISSA, but much higher than other algorithms. However, its upper quartile is smaller than ISSA, and the optimal value distribution is relatively concentrated, improving the robustness of the original algorithm. In F7, the accuracy of the optimal value solved by ISSA is greater than that of SSA, and the entire boxplot of ISSA is below SSA, which also improves the robustness of the original algorithm. The search accuracy of ISSA and HHO is the same, the median and mean values of ISSA are lower than HHO and the stability of ISSA is higher. In F8, HHO has greater robustness, the accuracy of the ISSA is significantly higher than that of SSA and it is concentrated close to the theoretical ideal value with minimal variation in the optimal value, which further increases robustness. For F11, the optimal value for ISSA, SSA and HHO is 0, and each of these three algorithms has a high level of robustness. Based on the corresponding F11 convergence curve in Figure 1, it can be seen that ISSA has a faster convergence speed. In summary, ISSA not only improves search accuracy, but also has high robustness.

    Figure 2.  Boxplot for algorithm.

    Orthogonal frequency division multiplexing (OFDM) [18] is the core technology of 4G networks, as a low-complexity transmission technology, it is widely used in broadcast systems as well as wireless LAN standards and has great advantages in terms of resistance to multipath fading, narrowband interference, multiple access and signal processing. The difficulty of this system is mainly to obtain the channel state information matrix accurately so as to recover the transmitted signal at the receiver side, so channel estimation is the key to achieve this step.

    The major traditional channel estimation methods are least squares (LS) [19], minimum mean square error (MMSE) [20], maximum likelihood [21] and Bayesian channel estimation [22]. The three major orthogonal frequency division multiplexing (OFDM) channel estimation methods are non-blind channel, blind channel and semi-blind channel estimation [23]. Among them, the performance of the blind channel estimation method is better than the semi-blind channel estimation, but its complexity is quite high and there are not many practical use cases. Non-blind channel estimation is based on pilots or training sequences. In order to track channel changes in real-time and reduce errors, pilot-based channel estimation algorithms are generally used. This method has problems such as high pilot overhead and poor robustness and performs poorly in low signal-to-noise ratio situations.

    The LS algorithm is used in pilot-based channel estimation to obtain the channel at the pilot location. Then, estimate the whole channel through interpolation algorithm and finally get the signal sent by the sender. The channel estimation based on pilot focuses on the design of pilot, the traditional guide frequency design method is fixed, generally using equal interval into the pilot. This pilot arrangement order is manually set, so it is impossible to obtain a lower bit error rate. Aiming at the defects of traditional pilot design, we designed a least square method based on an improved sparrow search algorithm (ISSA-LS). The improved sparrow search algorithm is used to determine the optimal position of pilots, the fitness value is taken as the average bit error rate (BER) of each experiment and ISSA is utilized to identify the pilot arrangement order with the lowest average bit error rate.

    The experimental signal modulation method are phase shift keying modulation (PSK) and quadrature amplitude modulation (QAM), the signal-to-noise ratio is 0-30, the number of subcarriers is 52, the number of guide frequency is 12, the number of population of the improved sparrow search algorithm is taken as 30 and the number of iterations is set to 50 (Figure 3). In 4PSK signals, the LS algorithm reduces the bit error rate to 0 when the SNR (signal-to-noise ratio) is 5, while ISSA-LS already reduces it to 0 when the SNR is 3. In the 8PSK signal, when the SNR reaches 8, the LS method decreases the bit error rate to 0, but ISSA-LS already does so when the ratio is 7. The bit error rate of ISSA-LS is significantly lower than LS at both low and high signal-to-noise ratios when the transmitter uses PSK as the modulation method. The bit error rate in 16QAM signals is reduced to 0 by the LS algorithm at a SNR of 7, whereas it has already fallen to 0 by ISSA-LS at a SNR of 6. As the SNR of 64QAM signals reaches 14, the LS algorithm reduces the bit error rate to 0, whereas the ISSA-LS method has already achieved 0 at 11. The performance of ISSA-LS at low signal-to-noise ratios is comparable to that of the LS algorithm when the modulation mode of the modulation transmitter is QAM. ISSA-LS has a substantially lower bit error rate than LS at high SNR. The performance of ISSA-LS improves as the SNR increases.

    Figure 3.  Bit error rate curve after pilot optimization.

    Figure 4 shows the error bar of the bit error rate curves of ISSA-LS and LS, twenty experiments were conducted, and error bars were drawn based on the mean and standard deviation of the bit error rate at different signal-to-noise ratios. It can be seen that the bit error rate of ISSA-LS algorithm is lower than that of LS. Overall, whether it is PSK modulation or QAM modulation, the least squares method optimized by the improved sparrow search algorithm (ISSA-LS) has a lower bit error rate. The performance is superior to traditional least squares (LS) methods in both low signal-to-noise and high signal-to-noise ratios.

    Figure 4.  Error bar of bit error rate.

    In this paper, a multi-strategy improved sparrow search algorithm is proposed. First, a sparrow population dynamic adjustment strategy is added to dynamically adjust the population size of discoverers and joiners, and with the increase of iterations, more discoverers find foraging directions for the whole population, the number of joiners for global search increases, which facilitates the algorithm to depart from a local optimum. In the position formula of the finders, an update mechanism in the mining stage of the honeypot optimization algorithm is introduced. After changing the location update formula, the algorithm's global search ability increases and can search in a larger range; the update formula of the joiners is perturbed by the perturbation operator and levy flight strategy, which further improves the algorithm's capacity to depart from the local optimum. Finally, the algorithm is tested in 13 test functions to verify the superiority of the algorithm with other algorithms, and the algorithm is applied to the pilot optimization in channel estimation and achieves a lower BER. However, there are some defects in this paper. For instance, the improved algorithm does not achieve better performance on F5, F6, F12 and F13 in the pilot optimization in the channel estimation; and the performance of the improved sparrow search algorithm is equivalent to that of the least square method when the signal-to-noise ratio is low. In a future study, we will strive to use various ways to improve the algorithm and its convergence accuracy in these test functions. The enhanced algorithm will then be applied to pilot optimization to increase the channel estimate accuracy even more.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work is supported by the Tianjin Natural Science Foundation (No. 20JCYBJC00320), College Students' innovation and Entrepreneurship Project (No. 2022SKYZ313, No. 2022SKYZ390) and Innovation and Entrepreneurship Project for College Students.

    The authors declare there is no conflict of interest.



    Conflict of interest



    All authors declare no conflict of interest

    [1] Fiorino S, Tateo F, Biase D, et al. (2021) SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol 16: 1105-1133. https://doi.org/10.2217/fmb-2021-0064
    [2] Fares A (2013) Factors influencing the seasonal patterns of infectious diseases. Int J Prev Med 4: 128-132.
    [3] Price RHM, Graham C, Ramalingam S (2019) Association between viral seasonality and meteorological factors. Sci Rep 9: 929. https://doi.org/10.1038/s41598-018-37481-y
    [4] Juthani PV, Gupta A, Borges KA, et al. (2021) Hospitalisation among vaccine breakthrough COVID-19 infections. Lancet Infect Dis 21: 1485-1486. https://doi.org/10.1016/S1473-3099(21)00558-2
    [5] Rivasi G, Bulgaresi M, Mossello E, et al. (2021) Course and Lethality of SARS-CoV-2 Epidemic in Nursing Homes after Vaccination in Florence, Italy. Vaccines (Basel) 9: 1174. https://doi.org/10.3390/vaccines9101174
    [6] COVID-19 vaccine effectiveness. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/
    [7] Afrough B, Dowall S, Hewson R (2019) Emerging viruses and current strategies for vaccine intervention. Clin Exp Immunol 196: 157-166. https://doi.org/10.1111/cei.13295
    [8] Calina D, Docea AO, Petrakis D, et al. (2020) Towards effective COVID19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med 46: 3-16. https://doi.org/10.3892/ijmm.2020.4596
    [9] Castro C, Arnold JJ, Cameron CE (2005) Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res 107: 141-149. https://doi.org/10.1016/j.virusres.2004.11.004
    [10] Smith DB, Bukh J, Kuiken C, et al. (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59: 318-327. https://doi.org/10.1002/hep.26744
    [11] Yuan M, Huang D, Lee CD, et al. (2021) Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science 373: 818-823. https://doi.org/10.1126/science.abh1139
    [12] Yewdell JW (2021) Antigenic drift: Understanding COVID-19. Immunity 54: 2681-2687. https://doi.org/10.1016/j.immuni.2021.11.016
    [13] Vasireddy D, Vanaparthy R, Mohan G, et al. (2021) Review of COVID-19 variants and COVID-19 vaccine efficacy: What the clinician should know?. J Clin Med Res 13: 317-325. https://doi.org/10.14740/jocmr4518
    [14] Hodgson SH, Mansatta K, Mallett G, et al. (2021) What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis 21: e26-e35. https://doi.org/10.1016/S1473-3099(20)30773-8
    [15] Andrews N, Tessier E, Stowe J, et al. (2021) Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK. medRxiv . https://doi.org/10.1101/2021.09.15.21263583
    [16] Bergwerk M, Gonen T, Lustig Y, et al. (2021) Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med 385: 1474-1484. https://doi.org/10.1056/NEJMoa2109072
    [17] Cohn BA, Cirillo PM, Murphy CC, et al. (2022) SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science 375: 331-336. https://doi.org/10.1126/science.abm0620
    [18] Rzymski P, Camargo CA, Fal A, et al. (2021) COVID-19 vaccine boosters: The good, the bad, and the ugly. Vaccines (Basel) 9: 1299. https://doi.org/10.3390/vaccines9111299
    [19] Gazit S, Mizrahi B, Kalkstein N, et al. (2021) BNT162b2 mRNA vaccine effectiveness given confirmed exposure: Analysis of household members of COVID-19 patients. Clin Infect Dis 75: e73-e740. https://doi.org/10.1093/cid/ciab973
    [20] Chen X, Wang W, Chen X, et al. (2022) Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. BMC Med 20: 36. https://doi.org/10.1186/s12916-022-02249-9
    [21] Levin EG, Lustig Y, Cohen C, et al. (2021) Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med 385: e84. https://doi.org/10.1056/NEJMoa2114583
    [22] Gao YD, Ding M, Dong X, et al. (2021) Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 76: 428-455. https://doi.org/10.1111/all.14657
    [23] WHOCOVID-19: Booster Shots (2021). Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-53---covid-19-booster-shots.
    [24] WHOCoronavirus disease (COVID-19): Vaccines (2022). Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines
    [25] Bar-On YM, Goldberg Y, Mandel M, et al. (2021) Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med 385: 1393-1400. https://doi.org/10.1056/NEJMoa2114255
    [26] Krause PR, Fleming TR, Peto R, et al. (2021) Considerations in boosting COVID-19 vaccine immune responses. Lancet 398: 1377-1380. https://doi.org/10.1016/S0140-6736(21)02046-8
    [27] Lam JH, Smith FL, Baumgarth N (2020) B cell activation and response regulation during viral infections. Viral Immunol 33: 294-306. https://doi.org/10.1089/vim.2019.0207
    [28] Laidlaw BJ, Craft JE, Kaech SM (2016) The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat Rev Immunol 16: 102-111. https://doi.org/10.1038/nri.2015.10
    [29] Kervevan J, Chakrabarti LA (2021) Role of CD4+ T cells in the control of viral infections: Recent advances and open questions. Int J Mol Sci 22: 523. https://doi.org/10.3390/ijms22020523
    [30] Sallusto F (2016) Heterogeneity of Human CD4(+) T cells against microbes. Annu Rev Immunol 34: 317-334. https://doi.org/10.1146/annurev-immunol-032414-112056
    [31] Altmann DM, Boyton RJ, Beale R (2021) Immunity to SARS-CoV-2 variants of concern. Science 371: 1103-1104. https://doi.org/10.1126/science.abg7404
    [32] Kramer B, Knoll R, Bonaguro L, et al. (2021) Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 54: 2650-2669 e2614. https://doi.org/10.1016/j.immuni.2021.09.002
    [33] Leem G, Cheon S, Lee H, et al. (2021) Abnormality in the NK-cell population is prolonged in severe COVID-19 patients. J Allergy Clin Immunol 148: 996-1006 e1018. doi:10.1016/j.jaci.2021.07.022
    [34] Peng Y, Mentzer AJ, Liu G, et al. (2020) Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol 21: 1336-1345. https://doi.org/10.1038/s41590-020-0782-6
    [35] Min YQ, Huang M, Sun X, et al. (2021) Immune evasion of SARS-CoV-2 from interferon antiviral system. Comput Struct Biotechnol J 19: 4217-4225. https://doi.org/10.1016/j.csbj.2021.07.023
    [36] Rydyznski Moderbacher C, Ramirez SI, Dan JM, et al. (2020) Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183: 996-1012 e1019. https://doi.org/10.1016/j.cell.2020.09.038
    [37] Tan AT, Linster M, Tan CW, et al. (2021) Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep 34: 108728. https://doi.org/10.1016/j.celrep.2021.108728
    [38] Carsetti R, Zaffina S, Piano Mortari E, et al. (2020) Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol 11: 610300. https://doi.org/10.3389/fimmu.2020.610300
    [39] Jordan SC, Shin BH, Gadsden TM, et al. (2021) T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals. Cell Mol Immunol 18: 2554-2556. https://doi.org/10.1038/s41423-021-00767-9
    [40] Neidleman J, Luo X, George AF, et al. (2021) Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep 36: 109414. https://doi.org/10.1016/j.celrep.2021.109414
    [41] Swadling L, Maini MK (2020) T cells in COVID-19 - united in diversity. Nat Immunol 21: 1307-1308. https://doi.org/10.1038/s41590-020-0798-y
    [42] Mileto D, Fenizia C, Cutrera M, et al. (2021) SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response. Emerg Microbes Infect 10: 2235-2243. https://doi.org/10.1080/22221751.2021.2004866
    [43] Neidleman J, Luo X, Frouard J, et al. (2020) SARS-CoV-2-Specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential. Cell Rep Med 1: 100081. https://doi.org/10.1016/j.xcrm.2020.100081
    [44] Yin SW, Zhou Z, Wang JL, et al. (2021) Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Virol J 18: 126. https://doi.org/10.1186/s12985-021-01597-x
    [45] Balachandran H, Phetsouphanh C, Agapiou D, et al. (2022) Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses. Cell Rep 38: 110345. https://doi.org/10.1016/j.celrep.2022.110345
    [46] Gurevich M, Zilkha-Falb R, Sonis P, et al. (2022) SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis 115: 208-214. https://doi.org/10.1016/j.ijid.2021.12.309
    [47] Soresina A, Moratto D, Chiarini M, et al. (2020) Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol 31: 565-569. https://doi.org/10.1111/pai.13263
    [48] Zhao Q, Meng M, Kumar R, et al. (2020) Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis 96: 131-135. https://doi.org/10.1016/j.ijid.2020.04.086
    [49] De Biasi S, Meschiari M, Gibellini L, et al. (2020) Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11: 3434. https://doi.org/10.1038/s41467-020-17292-4
    [50] Mathew D, Giles JR, Baxter AE, et al. (2020) Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369: eabc8511. https://doi.org/10.1126/science.abc8511
    [51] Zhang J, Lin H, Ye B, et al. (2021) One-year sustained cellular and humoral immunities of COVID-19 convalescents. Clin Infect Dis 75: e1072-e1081. https://doi.org/10.1093/cid/ciab884
    [52] Altman JD, Moss PA, Goulder PJ, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96. https://doi.org/10.1126/science.274.5284.94
    [53] Maini MK, Boni C, Ogg GS, et al. (1999) Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 117: 1386-1396. https://doi.org/10.1016/S0016-5085(99)70289-1
    [54] Ogg GS, McMichael AJ (1998) HLA-peptide tetrameric complexes. Curr Opin Immunol 10: 393-396. https://doi.org/10.1016/S0952-7915(98)80110-6
    [55] Zhu F, Eckels DD (2002) Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL. Hum Immunol 63: 710-718. https://doi.org/10.1016/S0198-8859(02)00430-5
    [56] Mondelli M, Vergani GM, Alberti A, et al. (1982) Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129: 2773-2778.
    [57] Maini MK, Boni C, Lee CK, et al. (2000) The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191: 1269-1280. https://doi.org/10.1084/jem.191.8.1269
    [58] Walewska-Zielecka B, Madalinski K, Jablonska J, et al. (2008) Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression. World J Gastroenterol 14: 4040-4046. https://doi.org/10.3748/wjg.14.4040
    [59] Wang H, Wu B, Li L, et al. (2017) Hepatic expansion of virus-specific CD8(+)BTLA(+) T cells with regulatory properties in chronic hepatitis B virus infection. Cell Immunol 311: 36-45. https://doi.org/10.1016/j.cellimm.2016.10.002
    [60] Welsh RM, Selin LK (2002) No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2: 417-426. https://doi.org/10.1038/nri820
    [61] Tough DF, Borrow P, Sprent J (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950. https://doi.org/10.1126/science.272.5270.1947
    [62] Kim TS, Shin EC (2019) The activation of bystander CD8(+) T cells and their roles in viral infection. Exp Mol Med 51: 1-9. https://doi.org/10.1038/s12276-019-0316-1
    [63] van Aalst S, Ludwig IS, van der Zee R, et al. (2017) Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant. PLoS One 12: e0177365. https://doi.org/10.1371/journal.pone.0177365
    [64] Martin MD, Shan Q, Xue HH, et al. (2017) Time and antigen-stimulation history influence memory CD8 T cell bystander responses. Front Immunol 8: 634. https://doi.org/10.3389/fimmu.2017.00634
    [65] Zhang X, Sun S, Hwang I, et al. (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8: 591-599. https://doi.org/10.1016/S1074-7613(00)80564-6
    [66] Raue HP, Brien JD, Hammarlund E, et al. (2004) Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol 173: 6873-6881. https://doi.org/10.4049/jimmunol.173.11.6873
    [67] Xu D, Fu J, Jin L, et al. (2006) Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 177: 739-747. https://doi.org/10.4049/jimmunol.177.1.739
    [68] Wu W, Li J, Chen F, et al. (2010) Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 25: 750-757. https://doi.org/10.1111/j.1440-1746.2009.06154.x
    [69] Chen G, Wu D, Guo W, et al. (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130: 2620-2629. https://doi.org/10.1172/JCI137244
    [70] Datta U, Sehgal S, Pal SR, et al. (1982) Lymphocyte subpopulation in acute viral hepatitis. Gut 23: 927-930. https://doi.org/10.1136/gut.23.11.927
    [71] Bertoletti A, Le Bert N, Qui M, et al. (2021) SARS-CoV-2-specific T cells in infection and vaccination. Cell Mol Immunol 18: 2307-2312. https://doi.org/10.1038/s41423-021-00743-3
    [72] Bertoletti A, Ferrari C, Fiaccadori F, et al. (1991) HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 88: 10445-10449. https://doi.org/10.1073/pnas.88.23.10445
    [73] Penna A, Chisari FV, Bertoletti A, et al. (1991) Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174: 1565-1570. https://doi.org/10.1084/jem.174.6.1565
    [74] Penna A, Del Prete G, Cavalli A, et al. (1997) Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25: 1022-1027. https://doi.org/10.1002/hep.510250438
    [75] Li J, Wang J, Kang AS, et al. (2020) Mapping the T cell response to COVID-19. Signal Transduct Target Ther 5: 112. https://doi.org/10.1038/s41392-020-00228-1
    [76] Grifoni A, Weiskopf D, Ramirez SI, et al. (2020) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181: 1489-1501 e1415. https://doi.org/10.1016/j.cell.2020.05.015
    [77] Ferretti AP, Kula T, Wang Y, et al. (2020) Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity 53: 1095-1107 e1093. https://doi.org/10.1016/j.immuni.2020.10.006
    [78] Zhu C, He G, Yin Q, et al. (2021) Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge. J Med Virol 93: 5729-5741. https://doi.org/10.1002/jmv.27132
    [79] Zhao J, Wang L, Schank M, et al. (2021) SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Virus Res 304: 198508. https://doi.org/10.1016/j.virusres.2021.198508
    [80] Szabo PA, Dogra P, Gray JI, et al. (2021) Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 54: 797-814 e796. https://doi.org/10.1016/j.immuni.2021.03.005
    [81] Saris A, Reijnders TDY, Nossent EJ, et al. (2021) Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorax 76: 1010-1019. https://doi.org/10.1136/thoraxjnl-2020-216256
    [82] Grau-Exposito J, Sanchez-Gaona N, Massana N, et al. (2021) Peripheral and lung resident memory T cell responses against SARS-CoV-2. Nat Commun 12: 3010. https://doi.org/10.1038/s41467-021-23333-3
    [83] Grant RA, Morales-Nebreda L, Markov NS, et al. (2021) Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 590: 635-641. https://doi.org/10.1038/s41586-020-03148-w
    [84] Urra JM, Cabrera CM, Porras L, et al. (2020) Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients. Clin Immunol 217: 108486. https://doi.org/10.1016/j.clim.2020.108486
    [85] Zimmermann P, Curtis N (2019) Factors that influence the immune response to vaccination. Clin Microbiol Rev 32: e00084-18. https://doi.org/10.1128/CMR.00084-18
    [86] Olliaro P, Torreele E, Vaillant M (2021) COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe 2: e279-e280. https://doi.org/10.1016/S2666-5247(21)00069-0
    [87] Fiolet T, Kherabi Y, MacDonald CJ, et al. (2022) Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect 28: 202-221. https://doi.org/10.1016/j.cmi.2021.10.005
    [88] Li H, Yu J, Cao B (2021) SARS-CoV-2 vaccination for immune-comprised patients: More is required. Lancet Reg Health Eur 9: 100191. https://doi.org/10.1016/j.lanepe.2021.100191
    [89] Weinberger B (2021) Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 18: 38. https://doi.org/10.1186/s12979-021-00249-6
    [90] Shroff RT, Chalasani P, Wei R, et al. (2021) Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors. Nat Med 27: 2002-2011. https://doi.org/10.1038/s41591-021-01542-z
    [91] Alexander JL, Kennedy NA, Lees CW, et al. (2021) SARS-CoV-2 vaccination for patients with inflammatory bowel disease-Authors' reply. Lancet Gastroenterol Hepatol 6: 523-524. https://doi.org/10.1016/S2468-1253(21)00194-1
    [92] Moor MB, Suter-Riniker F, Horn MP, et al. (2021) Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. Lancet Rheumatol 3: e789-e797. https://doi.org/10.1016/S2665-9913(21)00251-4
    [93] Boyarsky BJ, Werbel WA, Avery RK, et al. (2021) Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 325: 2204-2206. https://doi.org/10.1001/jama.2021.7489
    [94] Rabinowich L, Grupper A, Baruch R, et al. (2021) Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol 75: 435-438. https://doi.org/10.1016/j.jhep.2021.04.020
    [95] Meng Z, Zhang J, Shi J, et al. (2020) Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness. Hum Vaccin Immunother 16: 2680-2689. https://doi.org/10.1080/21645515.2020.1747375
    [96] Collier DA, Ferreira I, Kotagiri P, et al. (2021) Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596: 417-422. https://doi.org/10.1038/s41586-021-03739-1
    [97] Cerqueira-Silva T, Oliveira VA, Boaventura VS, et al. (2022) Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study. Lancet Reg Health Am 6: 100154. https://doi.org/10.1016/j.lana.2021.100154
    [98] Botton J, Dray-Spira R, Baricault B, et al. (2022) Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines. Vaccine 40: 414-417. https://doi.org/10.1016/j.vaccine.2021.12.009
    [99] Ventura MT, Casciaro M, Gangemi S, et al. (2017) Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clin Mol Allergy 15: 21. https://doi.org/10.1186/s12948-017-0077-0
    [100] Kirkwood KL (2018) Inflammaging. Immunol Invest 47: 770-773. https://doi.org/10.1080/08820139.2018.1552392
    [101] Kuderer NM, Choueiri TK, Shah DP, et al. (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395: 1907-1918. https://doi.org/10.1016/S0140-6736(20)31187-9
    [102] Monin L, Laing AG, Munoz-Ruiz M, et al. (2021) Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol 22: 765-778. https://doi.org/10.1016/S1470-2045(21)00213-8
    [103] Latif MB, Shukla S, Del Rio Estrada PM, et al. (2021) Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection. Transl Res . https://doi.org/10.1016/j.trsl.2021.12.001
    [104] Mansi L, Spehner L, Daguindau E, et al. (2021) Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients. Eur J Cancer 150: 1-9. https://doi.org/10.1016/j.ejca.2021.03.033
    [105] Luqmani YA, El Hashim A (2021) The COVID-19 pandemic: A health crisis managed or a panic response with disastrous future consequences?. Med Princ Pract 31: 1-10. https://doi.org/10.1159/000520258
    [106] Tarke A, Sidney J, Methot N, et al. (2021) Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals. Cell Rep Med 2: 100355. https://doi.org/10.1016/j.xcrm.2021.100355
    [107] Thanabalan A, Kiarie EG (2021) Influence of feeding Omega-3 Polyunsaturated fatty acids to broiler breeders on indices of immunocompetence, gastrointestinal, and skeletal development in broiler chickens. Front Vet Sci 8: 653152. https://doi.org/10.3389/fvets.2021.653152
    [108] Hogenkamp A, van Vlies N, Fear AL, et al. (2011) Dietary fatty acids affect the immune system in male mice sensitized to ovalbumin or vaccinated with influenza. J Nutr 141: 698-702. https://doi.org/10.3945/jn.110.135863
    [109] Yuan J, Roshdy AR, Guo Y, et al. (2014) Effect of dietary vitamin A on reproductive performance and immune response of broiler breeders. PLoS One 9: e105677. https://doi.org/10.1371/journal.pone.0105677
    [110] Quigley JD, Hill TM, Dennis TS, et al. (2021) Effects of mixed tocopherols added to milk replacer and calf starter on intake, growth, and indices of stress. J Dairy Sci 104: 9769-9783. https://doi.org/10.3168/jds.2020-19929
    [111] Nonnecke BJ, Foote MR, Miller BL, et al. (2009) Effects of chronic environmental cold on growth, health, and select metabolic and immunologic responses of preruminant calves. J Dairy Sci 92: 6134-6143. https://doi.org/10.3168/jds.2009-2517
    [112] Calder PC (2013) Feeding the immune system. Proc Nutr Soc 72: 299-309. https://doi.org/10.1017/S0029665113001286
    [113] Friedman A, Sklan D (1995) Effect of dietary fatty acids on antibody production and fatty acid composition of lymphoid organs in broiler chicks. Poult Sci 74: 1463-1469. https://doi.org/10.3382/ps.0741463
    [114] Korver DR, Klasing KC (1997) Dietary fish oil alters specific and inflammatory immune responses in chicks. J Nutr 127: 2039-2046. https://doi.org/10.1093/jn/127.10.2039
    [115] Hayek MG, Han SN, Wu D, et al. (1999) Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice. J Nutr 129: 32-38. https://doi.org/10.1093/jn/129.1.32
    [116] Andresen AMS, Lutfi E, Ruyter B, et al. (2019) Interaction between dietary fatty acids and genotype on immune response in Atlantic salmon (Salmo salar) after vaccination: A transcriptome study. PLoS One 14: e0219625. https://doi.org/10.1371/journal.pone.0219625
    [117] Carman JA, Pond L, Nashold F, et al. (1992) Immunity to Trichinella spiralis infection in vitamin A-deficient mice. J Exp Med 175: 111-120. https://doi.org/10.1084/jem.175.1.111
    [118] Lee GY, Han SN (2018) The role of vitamin E in immunity. Nutrients 10: 1614. https://doi.org/10.3390/nu10111614
    [119] Penkert RR, Surman SL, Jones BG, et al. (2016) Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells. Int Immunol 28: 139-152. https://doi.org/10.1093/intimm/dxv064
    [120] Wang Z, Wang Y, Xu B, et al. (2017) Vitamin D improves immune function in immunosuppressant mice induced by glucocorticoid. Biomed Rep 6: 120-124. https://doi.org/10.3892/br.2016.817
    [121] Surman SL, Jones BG, Woodland DL, et al. (2017) Enhanced CD103 expression and reduced frequencies of virus-specific CD8(+) T cells among airway lymphocytes after influenza vaccination of mice deficient in vitamins A + D. Viral Immunol 30: 737-743. https://doi.org/10.1089/vim.2017.0086
    [122] Surman SL, Penkert RR, Jones BG, et al. (2016) vitamin supplementation at the time of immunization with a cold-adapted influenza virus vaccine corrects poor mucosal antibody responses in mice deficient for vitamins A and D. Clin Vaccine Immunol 23: 219-227. https://doi.org/10.1128/CVI.00739-15
    [123] Meydani SN, Meydani M, Verdon CP, et al. (1986) Vitamin E supplementation suppresses prostaglandin E1(2) synthesis and enhances the immune response of aged mice. Mech Ageing Dev 34: 191-201. https://doi.org/10.1016/0047-6374(86)90034-5
    [124] Marko MG, Ahmed T, Bunnell SC, et al. (2007) Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. J Immunol 178: 1443-1449. https://doi.org/10.4049/jimmunol.178.3.1443
    [125] Marko MG, Pang HJ, Ren Z, et al. (2009) Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. J Nutr 139: 1192-1197. https://doi.org/10.3945/jn.108.103416
    [126] Quintilio W, de Freitas FA, Rodriguez D, et al. (2016) Vitamins as influenza vaccine adjuvant components. Arch Virol 161: 2787-2795. https://doi.org/10.1007/s00705-016-2994-5
    [127] Radhakrishnan AK, Mahalingam D, Selvaduray KR, et al. (2013) Supplementation with natural forms of vitamin E augments antigen-specific TH1-type immune response to tetanus toxoid. Biomed Res Int 2013: 782067. https://doi.org/10.1155/2013/782067
    [128] Kelley DS, Taylor PC, Nelson GJ, et al. (1997) Effects of dietary arachidonic acid on human immune response. Lipids 32: 449-456. https://doi.org/10.1007/s11745-997-0059-3
    [129] Calder PC (1998) Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz J Med Biol Res 31: 467-490. https://doi.org/10.1590/S0100-879X1998000400002
    [130] Al-Khalaifah H (2020) Modulatory effect of dietary polyunsaturated fatty acids on immunity, represented by phagocytic activity. Front Vet Sci 7: 569939. https://doi.org/10.3389/fvets.2020.569939
    [131] Dzopalic T, Bozic-Nedeljkovic B, Jurisic V (2021) The role of vitamin A and vitamin D in modulation of the immune response with a focus on innate lymphoid cells. Cent Eur J Immunol 46: 264-269. https://doi.org/10.5114/ceji.2021.103540
    [132] Schwalfenberg GK (2011) A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 55: 96-108. https://doi.org/10.1002/mnfr.201000174
    [133] Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8: 685-698. https://doi.org/10.1038/nri2378
    [134] Huang Z, Liu Y, Qi G, et al. (2018) Role of vitamin A in the immune system. J Clin Med 7: 258. https://doi.org/10.3390/jcm7090258
    [135] Motoyama KR, Curb JD, Kadowaki T, et al. (2009) Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Am J Clin Nutr 90: 49-55. https://doi.org/10.3945/ajcn.2008.26761
    [136] Abdelmagid SA, Clarke SE, Nielsen DE, et al. (2015) Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults. PLoS One 10: e0116195. https://doi.org/10.1371/journal.pone.0116195
    [137] Mariamenatu AH, Abdu EM (2021) Overconsumption of Omega-6 Polyunsaturated fatty acids (PUFAs) versus deficiency of Omega-3 PUFAs in modern-day diets: The disturbing factor for their “balanced antagonistic metabolic functions” in the human body. J Lipids 2021: 8848161. https://doi.org/10.1155/2021/8848161
    [138] Han X, Ding S, Lu J, et al. (2022) Global, regional, and national burdens of common micronutrient deficiencies from 1990 to 2019: A secondary trend analysis based on the Global Burden of Disease 2019 study. E Clinical Medicine 44: 101299. https://doi.org/10.1016/j.eclinm.2022.101299
    [139] Zhao T, Liu S, Zhang R, et al. (2022) Global burden of vitamin A deficiency in 204 countries and territories from 1990–2019. Nutrients 14: 950. https://doi.org/10.2139/ssrn.4005132
    [140] Palacios C, Gonzalez L (2014) Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol 144 Pt A: 138-145. https://doi.org/10.1016/j.jsbmb.2013.11.003
    [141] Sundaram ME, Talbot HK, Zhu Y, et al. (2013) Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine 31: 2057-2061. https://doi.org/10.1016/j.vaccine.2013.02.028
    [142] Lee MD, Lin CH, Lei WT, et al. (2018) Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis. Nutrients 10: 409. https://doi.org/10.3390/nu10040409
    [143] (2000) Institute of Medicine (US) Panel on Dietary Antioxidants and Related CompoundsDietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington (DC): National Academies Press.
    [144] Peter S, Friedel A, Roos FF, et al. (2015) A systematic review of global alpha-tocopherol status as assessed by nutritional intakelevels and blood serum concentrations. Int J Vitam Nutr Res 85: 261-281. https://doi.org/10.1024/0300-9831/a000281
    [145] Ford ES, Schleicher RL, Mokdad AH, et al. (2006) Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 84: 375-383. https://doi.org/10.1093/ajcn/84.1.375
    [146] Malik A, Eggersdorfer M, Trilok-Kumar G (2021) Vitamin E status in healthy population in Asia: A review of current literature. Int J Vitam Nutr Res 91: 356-369. https://doi.org/10.1024/0300-9831/a000590
    [147] Meydani SN, Han SN, Wu D (2005) Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev 205: 269-284. https://doi.org/10.1111/j.0105-2896.2005.00274.x
    [148] Murphy S, West KP, Greenough WB, et al. (1992) Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age Ageing 21: 435-439. https://doi.org/10.1093/ageing/21.6.435
    [149] Buzina-Suboticanec K, Buzina R, Stavljenic A, et al. (1998) Ageing, nutritional status and immune response. Int J Vitam Nutr Res 68: 133-141.
    [150] Wu D, Meydani SN (2008) Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol 84: 900-914. https://doi.org/10.1189/jlb.0108023
    [151] Wu D, Meydani SN (2014) Age-associated changes in immune function: impact of vitamin E intervention and the underlying mechanisms. Endocr Metab Immune Disord Drug Targets 14: 283-289. https://doi.org/10.2174/1871530314666140922143950
    [152] Camargo CQ, Brunetta HS, Nunes EA (2018) Effects of cotreatment with omega-3 polyunsaturated fatty acids and anticancer agents on oxidative stress parameters: a systematic review of in vitro, animal, and human studies. Nutr Rev 76: 765-777. https://doi.org/10.1093/nutrit/nuy029
    [153] Story MJ (2021) Zinc, omega-3 polyunsaturated fatty acids and vitamin D: An essential combination for prevention and treatment of cancers. Biochimie 181: 100-122. https://doi.org/10.1016/j.biochi.2020.11.019
    [154] Yuen RC, Tsao SY (2021) Embracing cancer immunotherapy with vital micronutrients. World J Clin Oncol 12: 712-724. https://doi.org/10.5306/wjco.v12.i9.712
    [155] Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60. https://doi.org/10.1146/annurev.iy.13.040195.000333
    [156] Matchett WE, Joag V, Stolley JM, et al. (2021) Cutting Edge: Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity. J Immunol 207: 376-379. https://doi.org/10.4049/jimmunol.2100421
    [157] Fiorino S, Gallo C, Zippi M, et al. (2020) Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy. Aging Clin Exp Res 32: 2115-2131. https://doi.org/10.1007/s40520-020-01669-y
    [158] Fiorino S, Zippi M, Gallo C, et al. (2021) The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities. Br J Nutr 125: 275-293. https://doi.org/10.1017/S0007114520002913
    [159] Husson MO, Ley D, Portal C, et al. (2016) Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids. J Infect 73: 523-535. https://doi.org/10.1016/j.jinf.2016.10.001
    [160] Chiang N, Serhan CN (2020) Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 64: 443-462. https://doi.org/10.1042/EBC20200018
    [161] Panigrahy D, Gilligan MM, Huang S, et al. (2020) Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?. Cancer Metastasis Rev 39: 337-340. https://doi.org/10.1007/s10555-020-09889-4
    [162] Gallo CG, Fiorino S, Posabella G, et al. (2022) The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 159: 106619. https://doi.org/10.1016/j.prostaglandins.2022.106619
    [163] Sedighiyan M, Abdollahi H, Karimi E, et al. (2021) Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with Covid-19: A randomised clinical trial. Int J Clin Pract 75: e14854. https://doi.org/10.1111/ijcp.14854
    [164] Rogero MM, Leao MC, Santana TM, et al. (2020) Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med 156: 190-199. https://doi.org/10.1016/j.freeradbiomed.2020.07.005
    [165] Ross AC, Chen Q, Ma Y (2011) Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm 86: 103-126. https://doi.org/10.1016/B978-0-12-386960-9.00005-8
    [166] Azzi L, Dalla Gasperina D, Veronesi G, et al. (2022) Mucosal immune response in BNT162b2 COVID-19 vaccine recipients. E Bio Medicine 75: 103788. https://doi.org/10.1016/j.ebiom.2021.103788
    [167] Hughes DA, Norton R (2009) Vitamin D and respiratory health. Clin Exp Immunol 158: 20-25. https://doi.org/10.1111/j.1365-2249.2009.04001.x
    [168] Parekh D, Thickett DR, Turner AM (2013) Vitamin D deficiency and acute lung injury. Inflamm Allergy Drug Targets 12: 253-261. https://doi.org/10.2174/18715281113129990049
    [169] Remmelts HH, van de Garde EM, Meijvis SC, et al. (2012) Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis 55: 1488-1494. https://doi.org/10.1093/cid/cis751
    [170] Dancer RC, Parekh D, Lax S, et al. (2015) Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 70: 617-624. https://doi.org/10.1136/thoraxjnl-2014-206680
    [171] Borsche L, Glauner B, von Mendel J (2021) COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/mL 25(OH)D3: results of a systematic review and meta-analysis. Nutrients 13: 3596. https://doi.org/10.3390/nu13103596
    [172] Ebrahimzadeh A, Mohseni S, Narimani B, et al. (2021) Association between vitamin D status and risk of covid-19 in-hospital mortality: A systematic review and meta-analysis of observational studies. Crit Rev Food Sci Nutr : 1-11. https://doi.org/10.1080/10408398.2021.2012419
    [173] Dissanayake HA, de Silva NL, Sumanatilleke M, et al. (2021) Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J Clin Endocrinol Metab 107: 1484-1502. https://doi.org/10.1210/clinem/dgab892
    [174] Tentolouris N, Samakidou G, Eleftheriadou I, et al. (2021) The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression. Diabetes Metab Res Rev : e3517. https://doi.org/10.1002/dmrr.3517
    [175] Hu Y, Kung J, Cave A, et al. (2022) Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci 25: 84-92. https://doi.org/10.18433/jpps32590
    [176] Chen J, Mei K, Xie L, et al. (2021) Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs. Nutr J 20: 89. https://doi.org/10.1186/s12937-021-00744-y
    [177] Pallast EG, Schouten EG, de Waart FG, et al. (1999) Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr 69: 1273-1281. https://doi.org/10.1093/ajcn/69.6.1273
    [178] Andreone P, Fiorino S, Cursaro C, et al. (2001) Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial. Antiviral Res 49: 75-81. https://doi.org/10.1016/S0166-3542(00)00141-8
    [179] Fiorino S, Loggi E, Verucchi G, et al. (2017) Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. Liver Int 37: 54-61. https://doi.org/10.1111/liv.13192
    [180] Gerner P, Posselt HG, Krahl A, et al. (2008) Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial. World J Gastroenterol 14: 7208-7213. https://doi.org/10.3748/wjg.14.7208
    [181] Dikici B, Dagli A, Ucmak H, et al. (2007) Efficacy of vitamin E in children with immunotolerant-phase chronic hepatitis B infection. Pediatr Int 49: 603-607. https://doi.org/10.1111/j.1442-200X.2007.02419.x
    [182] Fiorino S, Bacchi-Reggiani ML, Leandri P, et al. (2017) Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis. World J Hepatol 9: 333-342. https://doi.org/10.4254/wjh.v9.i6.333
  • This article has been cited by:

    1. Qinghua Li, Hu Shi, Wanting Zhao, Chunlu Ma, Enhanced Dung Beetle Optimization Algorithm for Practical Engineering Optimization, 2024, 12, 2227-7390, 1084, 10.3390/math12071084
    2. Kun Li, Hao Wu, Xinming Liu, Jianing Xu, Ying Han, Intelligent Diagnosis of Rolling Bearing Based on ICEEMDAN-WTD of Noise Reduction and Multi-Strategy Fusion Optimization SCNs, 2024, 12, 2169-3536, 36908, 10.1109/ACCESS.2024.3373554
    3. Ya‐Kun Zhang, Jian‐Bo Tong, Ze‐Lei Chang, Jing Yan, Xiao‐Yu Xing, Yu‐Lu Yang, Zhan Xue, QSAR Modeling of Pyridone Derivatives as α‐amylase Inhibitors Using Chemical Descriptors and Machine Learning, 2025, 10, 2365-6549, 10.1002/slct.202404214
    4. Fengtao Wei, Yue Feng, Xin Shi, Kai Hou, Improved sparrow search algorithm with adaptive multi-strategy hierarchical mechanism for global optimization and engineering problems, 2025, 28, 1386-7857, 10.1007/s10586-024-04883-9
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2190) PDF downloads(137) Cited by(1)

Figures and Tables

Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog